United States Biotechnology & Medical Research

Zyla Life Sciences (ZCOR)

Track

Stock chart
Ticker: ZCOR Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Riva Ridge Capital Management LP
1 sale — total 125,000 USD
Sale 30 Dec 2019
Value US$854,026.94 | Price 446.95 | Shares 3,651
Sale 23 Dec 2019
Value US$3,744,799.42 | Price 158.02 | Shares 54,022
Planned sale 2 Jan 2018
Value US$910.00 | Price 1.00 | Shares 910
Planned sale 2 Oct 2017
Value US$11,223.00 | Price 1.29 | Shares 8,700
Planned sale 2 Oct 2017
Value US$1,183.00 | Price 1.30 | Shares 910
Planned sale 3 Jul 2017
Value US$8,212.80 | Price 2.36 | Shares 3,480
Planned sale 3 Jul 2017
Value US$2,138.50 | Price 2.35 | Shares 910
Planned sale 3 Jul 2017
Value US$1,894.10 | Price 2.35 | Shares 806
Planned sale 30 Jun 2017
Value US$20,793.00 | Price 2.39 | Shares 8,700
Planned sale 3 Apr 2017
Value US$43,409.52 | Price 5.04 | Shares 8,613
Planned sale 3 Apr 2017
Value US$4,070.30 | Price 5.05 | Shares 806
Planned sale 31 Mar 2017
Value US$2,765.76 | Price 5.16 | Shares 536
Planned sale 31 Mar 2017
Value US$44,457.00 | Price 5.11 | Shares 8,700
Planned sale 20 Mar 2017
Value US$20,187.50 | Price 4.75 | Shares 4,250
Planned sale 3 Jan 2017
Value US$6,246.50 | Price 7.75 | Shares 806
Planned sale 3 Jan 2017
Value US$4,154.00 | Price 7.75 | Shares 536
Planned sale 3 Jan 2017
Value US$104,200.40 | Price 7.73 | Shares 13,480
Planned sale 30 Dec 2016
Value US$67,947.00 | Price 7.81 | Shares 8,700
Planned sale 3 Oct 2016
Value US$6,093.36 | Price 7.56 | Shares 806
Planned sale 3 Oct 2016
Value US$112,050.00 | Price 7.47 | Shares 15,000
Planned sale 3 Oct 2016
Value US$100,695.60 | Price 7.47 | Shares 13,480
Planned sale 30 Sep 2016
Value US$189,750.00 | Price 7.59 | Shares 25,000
Planned sale 30 Sep 2016
Value US$4,121.84 | Price 7.69 | Shares 536
Planned sale 30 Sep 2016
Value US$65,685.00 | Price 7.55 | Shares 8,700
Planned sale 6 Jul 2016
Value US$25,100.00 | Price 5.02 | Shares 5,000
Planned sale 5 Jul 2016
Value US$17,574.00 | Price 5.05 | Shares 3,480
Planned sale 5 Jul 2016
Value US$24,700.00 | Price 4.94 | Shares 5,000
Planned sale 1 Jul 2016
Value US$50,600.00 | Price 5.06 | Shares 10,000
Planned sale 1 Jul 2016
Value US$25,350.00 | Price 5.07 | Shares 5,000
Planned sale 30 Jun 2016
Value US$40,716.00 | Price 4.68 | Shares 8,700
Planned sale 30 Jun 2016
Value US$2,492.40 | Price 4.65 | Shares 536
Planned sale 5 Apr 2016
Value US$34,950.00 | Price 6.99 | Shares 5,000
Planned sale 5 Apr 2016
Value US$5,985.60 | Price 6.96 | Shares 860
Planned sale 4 Apr 2016
Value US$34,950.00 | Price 6.99 | Shares 5,000
Planned sale 1 Apr 2016
Value US$34,700.00 | Price 6.94 | Shares 5,000
Planned sale 1 Apr 2016
Value US$24,429.60 | Price 7.02 | Shares 3,480
Planned sale 31 Mar 2016
Value US$3,601.92 | Price 6.72 | Shares 536
Planned sale 31 Mar 2016
Value US$58,290.00 | Price 6.70 | Shares 8,700
Planned sale 11 Jan 2016
Value US$28,950.00 | Price 9.65 | Shares 3,000
Planned sale 8 Jan 2016
Value US$38,760.00 | Price 9.69 | Shares 4,000
Planned sale 7 Jan 2016
Value US$28,830.00 | Price 9.61 | Shares 3,000
Planned sale 6 Jan 2016
Value US$21,336.00 | Price 10.16 | Shares 2,100
Planned sale 5 Jan 2016
Value US$15,554.00 | Price 11.11 | Shares 1,400
Planned sale 4 Jan 2016
Value US$15,705.00 | Price 10.47 | Shares 1,500
Planned sale 4 Jan 2016
Value US$8,987.00 | Price 10.45 | Shares 860
Planned sale 4 Jan 2016
Value US$37,166.40 | Price 10.68 | Shares 3,480
Planned sale 31 Dec 2015
Value US$5,574.40 | Price 10.40 | Shares 536
Planned sale 31 Dec 2015
Value US$90,480.00 | Price 10.40 | Shares 8,700
Buy 11 Feb 2014
Value US$3,201,252.00 | Price 12.00 | Shares 266,771
Buy 11 Feb 2014
Value US$58,344.00 | Price 12.00 | Shares 4,862
Buy 11 Feb 2014
Value US$14,040.00 | Price 12.00 | Shares 1,170
Buy 11 Feb 2014
Value US$788,304.00 | Price 12.00 | Shares 65,692
Buy 11 Feb 2014
Value US$388,056.00 | Price 12.00 | Shares 32,338
Buy 11 Feb 2014
Value US$999,996.00 | Price 12.00 | Shares 83,333
Buy 11 Feb 2014
Value US$1,875,000.00 | Price 12.00 | Shares 156,250
Buy 11 Feb 2014
Value US$1,599,996.00 | Price 12.00 | Shares 133,333
Buy 11 Feb 2014
Value US$500,004.00 | Price 12.00 | Shares 41,667
Buy 11 Feb 2014
Value US$500,004.00 | Price 12.00 | Shares 41,667
Buy 11 Feb 2014
Value US$999,996.00 | Price 12.00 | Shares 83,333
Buy 11 Feb 2014
Value US$1,599,996.00 | Price 12.00 | Shares 133,333
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-01-10 2019-12-30 S Sale
Riva Ridge Capital Management LP
3,651 -19.9%
446.95
US$854,027 		3,651 -19.9% 446.95 US$854,027
2020-01-10 2019-12-23 S Sale
Riva Ridge Capital Management LP
54,022 -1.6%
158.02
US$3,744,799 		54,022 -1.6% 158.02 US$3,744,799
2018-01-03 2018-01-02 PlS Planned sale Shea Patrick M

Chief Commercial Officer

Officer
50,521 -48.9%
131.53
US$4,507,612 		50,521 -48.9% 131.53 US$4,507,612
2017-10-03 2017-10-02 PlS Planned sale
Strobeck Mark

Chief Operating Officer
8,700 -41.9%
1.29
US$11,223 		8,700 -41.9% 1.29 US$11,223
2017-10-03 2017-10-02 PlS Planned sale
Shea Patrick M

Chief Commercial Officer
910 -2.3%
1.30
US$1,183 		910 -2.3% 1.30 US$1,183
2017-07-06 2017-07-03 PlS Planned sale Musial Stan

Chief Financial Officer

Officer
3,480 -7.6%
2.36
US$8,213 		3,480 -7.6% 2.36 US$8,213
2017-07-06 2017-07-03 PlS Planned sale
Shea Patrick M

Chief Commercial Officer

Officer
910 -2.3%
2.35
US$2,138 		910 -2.3% 2.35 US$2,138
2017-07-06 2017-07-03 PlS Planned sale
VARKI PAUL

SVP, GC & Chief Compliance Off

Officer
806 -2.7%
2.35
US$1,894 		806 -2.7% 2.35 US$1,894
2017-07-05 2017-06-30 PlS Planned sale
Strobeck Mark

Chief Operating Officer

Officer
8,700 -29.5%
2.39
US$20,793 		8,700 -29.5% 2.39 US$20,793
2017-04-05 2017-04-03 PlS Planned sale Musial Stan

Chief Financial Officer
8,613 -15.8%
5.04
US$43,410 		8,613 -15.8% 5.04 US$43,410
2017-04-04 2017-04-03 PlS Planned sale VARKI PAUL

SVP, GC & Chief Compliance Off
806 -2.7%
5.05
US$4,070 		806 -2.7% 5.05 US$4,070
2017-04-04 2017-03-31 PlS Planned sale Dayno Jeffrey M.

Chief Medical Officer
536 -2.9%
5.16
US$2,766 		536 -2.9% 5.16 US$2,766
2017-03-31 2017-03-31 PlS Planned sale Strobeck Mark

Chief Operating Officer
8,700 -22.8%
5.11
US$44,457 		8,700 -22.8% 5.11 US$44,457
2017-03-21 2017-03-20 PlS Planned sale Shea Patrick M

Chief Commercial Officer
4,250 -10.0%
4.75
US$20,188 		4,250 -10.0% 4.75 US$20,188
2017-01-04 2017-01-03 PlS Planned sale
VARKI PAUL

SVP, GC & Chief Compliance Off
806 -2.6%
7.75
US$6,246 		806 -2.6% 7.75 US$6,246
2017-01-04 2017-01-03 PlS Planned sale
Dayno Jeffrey M.

Chief Medical Officer
536 -2.8%
7.75
US$4,154 		536 -2.8% 7.75 US$4,154
2017-01-04 2017-01-03 PlS Planned sale
Musial Stan

Chief Financial Officer
13,480 -19.8%
7.73
US$104,200 		13,480 -19.8% 7.73 US$104,200
2017-01-04 2016-12-30 PlS Planned sale
Strobeck Mark

Chief Operating Officer
8,700 -18.6%
7.81
US$67,947 		8,700 -18.6% 7.81 US$67,947
2016-10-04 2016-10-03 PlS Planned sale
VARKI PAUL

SVP, GC & Chief Compliance Off

Officer
806 -2.6%
7.56
US$6,093 		806 -2.6% 7.56 US$6,093
2016-10-04 2016-10-03 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
15,000 -6.0%
7.47
US$112,050 		15,000 -6.0% 7.47 US$112,050
2016-10-04 2016-10-03 PlS Planned sale
Musial Stan

Chief Financial Officer

Officer
13,480 -16.5%
7.47
US$100,696 		13,480 -16.5% 7.47 US$100,696
2016-10-03 2016-09-30 PlS Planned sale Strobeck Mark

Chief Operating Officer

Officer
25,000 -34.8%
7.59
US$189,750 		25,000 -34.8% 7.59 US$189,750
2016-10-03 2016-09-30 PlS Planned sale Dayno Jeffrey M.

Chief Medical Officer

Officer
536 -2.7%
7.69
US$4,122 		536 -2.7% 7.69 US$4,122
2016-10-03 2016-09-30 PlS Planned sale
Strobeck Mark

Chief Operating Officer

Officer
8,700 -10.8%
7.55
US$65,685 		8,700 -10.8% 7.55 US$65,685
2016-07-06 2016-07-06 PlS Planned sale Radie Robert S

President and CEO

Executive Director
5,000 -2.0%
5.02
US$25,100 		5,000 -2.0% 5.02 US$25,100
2016-07-06 2016-07-05 PlS Planned sale Musial Stan

Chief Financial Officer

Officer
3,480 -4.1%
5.05
US$17,574 		3,480 -4.1% 5.05 US$17,574
2016-07-06 2016-07-05 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
5,000 -1.9%
4.94
US$24,700 		5,000 -1.9% 4.94 US$24,700
2016-07-06 2016-07-01 PlS Planned sale
Musial Stan

Chief Financial Officer

Officer
10,000 -10.5%
5.06
US$50,600 		10,000 -10.5% 5.06 US$50,600
2016-07-06 2016-07-01 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
5,000 -1.9%
5.07
US$25,350 		5,000 -1.9% 5.07 US$25,350
2016-07-05 2016-06-30 PlS Planned sale
Strobeck Mark

Chief Business Officer

Officer
8,700 -9.7%
4.68
US$40,716 		8,700 -9.7% 4.68 US$40,716
2016-07-05 2016-06-30 PlS Planned sale
Dayno Jeffrey M.

Chief Medical Officer

Officer
536 -2.6%
4.65
US$2,492 		536 -2.6% 4.65 US$2,492
2016-04-06 2016-04-05 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
5,000 -1.9%
6.99
US$34,950 		5,000 -1.9% 6.99 US$34,950
2016-04-06 2016-04-05 PlS Planned sale Melloy Deanne F.

Chief Commercial Officer

Officer
860 -2.5%
6.96
US$5,986 		860 -2.5% 6.96 US$5,986
2016-04-05 2016-04-04 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
5,000 -1.8%
6.99
US$34,950 		5,000 -1.8% 6.99 US$34,950
2016-04-05 2016-04-01 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
5,000 -1.8%
6.94
US$34,700 		5,000 -1.8% 6.94 US$34,700
2016-04-04 2016-04-01 PlS Planned sale
Musial Stan

Chief Financial Officer

Officer
3,480 -3.5%
7.02
US$24,430 		3,480 -3.5% 7.02 US$24,430
2016-04-04 2016-03-31 PlS Planned sale Dayno Jeffrey M.

Chief Medical Officer

Officer
536 -2.6%
6.72
US$3,602 		536 -2.6% 6.72 US$3,602
2016-04-04 2016-03-31 PlS Planned sale Strobeck Mark

Chief Business Officer

Officer
8,700 -8.9%
6.70
US$58,290 		8,700 -8.9% 6.70 US$58,290
2016-01-12 2016-01-11 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
3,000 -1.1%
9.65
US$28,950 		3,000 -1.1% 9.65 US$28,950
2016-01-12 2016-01-08 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
4,000 -1.4%
9.69
US$38,760 		4,000 -1.4% 9.69 US$38,760
2016-01-12 2016-01-07 PlS Planned sale Radie Robert S

President and CEO

Executive Director
3,000 -1.0%
9.61
US$28,830 		3,000 -1.0% 9.61 US$28,830
2016-01-07 2016-01-06 PlS Planned sale Radie Robert S

President and CEO

Executive Director
2,100 -0.7%
10.16
US$21,336 		2,100 -0.7% 10.16 US$21,336
2016-01-07 2016-01-05 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
1,400 -0.5%
11.11
US$15,554 		1,400 -0.5% 11.11 US$15,554
2016-01-07 2016-01-04 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
1,500 -0.5%
10.47
US$15,705 		1,500 -0.5% 10.47 US$15,705
2016-01-05 2016-01-04 PlS Planned sale Melloy Deanne F.

Chief Commercial Officer

Officer
860 -2.4%
10.45
US$8,987 		860 -2.4% 10.45 US$8,987
2016-01-05 2016-01-04 PlS Planned sale Musial Stan

Chief Financial Officer

Officer
3,480 -3.4%
10.68
US$37,166 		3,480 -3.4% 10.68 US$37,166
2016-01-05 2015-12-31 PlS Planned sale
Dayno Jeffrey M.

Chief Medical Officer

Officer
536 -2.5%
10.40
US$5,574 		536 -2.5% 10.40 US$5,574
2016-01-05 2015-12-31 PlS Planned sale
Strobeck Mark

Chief Business Officer

Officer
8,700 -8.2%
10.40
US$90,480 		8,700 -8.2% 10.40 US$90,480
2014-02-13 2014-02-11 B Purchase Index Venture Associates III Ltd Large shareholder
266,771 +36.0%
12.00
US$3,201,252 		266,771 +36.0% 12.00 US$3,201,252
2014-02-13 2014-02-11 B Purchase Index Venture Associates III Ltd Large shareholder
4,862 +23.1%
12.00
US$58,344 		4,862 +23.1% 12.00 US$58,344
2014-02-13 2014-02-11 B Purchase Index Venture Associates III Ltd Large shareholder
1,170 +8.2%
12.00
US$14,040 		1,170 +8.2% 12.00 US$14,040
2014-02-13 2014-02-11 B Purchase Index Venture Associates III Ltd Large shareholder
65,692 +8.2%
12.00
US$788,304 		65,692 +8.2% 12.00 US$788,304
2014-02-13 2014-02-11 B Purchase Danish Biotech SPV I P/S Large shareholder
83,333 +36.0%
12.00
US$999,996 		83,333 +36.0% 12.00 US$999,996
2014-02-13 2014-02-11 B Purchase Danish Biotech SPV I P/S Large shareholder
156,250 +8.4%
12.00
US$1,875,000 		156,250 +8.4% 12.00 US$1,875,000
2014-02-13 2014-02-11 B Purchase Index Venture Associates III Ltd Large shareholder
32,338 +8.2%
12.00
US$388,056 		32,338 +8.2% 12.00 US$388,056
2014-02-12 2014-02-11 B Purchase SEGERROS ANDREAS Rutger Non-Executive Director Large shareholder
133,333 +7.7%
12.00
US$1,599,996 		133,333 +7.7% 12.00 US$1,599,996
2014-02-12 2014-02-11 B Purchase FORMELA JEAN FRANCOIS Non-Executive Director Large shareholder
41,667 +2.0%
12.00
US$500,004 		41,667 +2.0% 12.00 US$500,004
2014-02-12 2014-02-11 B Purchase Atlas Venture Fund VII L P Large shareholder
41,667 +2.0%
12.00
US$500,004 		41,667 +2.0% 12.00 US$500,004
2014-02-12 2014-02-11 B Purchase AGUIAR-LUCANDER RENEE Non-Executive Director
83,333 +36.0%
12.00
US$999,996 		83,333 +36.0% 12.00 US$999,996
2014-02-12 2014-02-11 B Purchase SUNSTONE LIFE SCIENCE VENTURES FUND II K/S Large shareholder
133,333 +7.7%
12.00
US$1,599,996 		133,333 +7.7% 12.00 US$1,599,996
Explore more

More insider trading research around Zyla Life Sciences

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America